drugset / Trial / NCT02321436
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate if early administration (i.e. within 12 weeks after stroke) of Dysport® 500 U injections may delay the appearance or the progression of upper limb symptomatic spasticity.
Timeline
- Start
- 2014-12
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 500 iu | Intramuscular |